Drug developer and pharma services group Abzena plc (LON:ABZA) is set to boost its already impressive revenue growth this year.
Results for the year to 31 March 2016 showed the top-line growing fast. Revenues rose 74% to £9.9mln from £5.7mln the year before.
Berkeley Energia Limited (LON:BKY), the uranium exploration group, is embarking on a drilling programme to enhance the potential of its Salamanca property in eastern Spain.
Twelve 250m holes are planned for the Zona 7, a high grade area that has already transformed the economics of the project.
DiamondCorp PLC (LON:DCP) said its recent auction of stones was a success while operational bottlenecks appear to be close to easing.
The South Africa-focused company has raked in US$436,597 from diamond sales, while two of three underground dump trucks acquired in April that have now been refurbished.
Copper and gold explorer Metminco Limited (LON:MNC ASX:MNC) has tied-up a US$45mln farm–out of its Los Calatos project in Peru.
A binding terms sheet has been signed with natural resources fund CD Capital Fund III that will see the money received in 3 tranches to pay for pre-feasibility and feasibility studies over the next 3-4 years.
Versarien Plc (LON:VRS) has unveiled a new partnership with Absolute Engineering.
The AIM-quoted graphene and advanced materials told investors that it has signed a Memorandum of Understanding for the new partnership, which will aim to develop novel technologies for the printing industry, including graphene enhanced composites.
Bushveld Minerals Limited (LON:BMN) has put an end to a long running legal dispute over assets in Madagascar.
The junior mining company told investors that its subsidiary Lemur Resources has reached a settlement with Madam Rahajasoamampionona Ramiaramanana, the claimant, in respect of mining licence 4578, part of the Imaloto Power Project coal concession.
Eckoh (LON:ECK) notched up its third successive year of double digit percentage revenue and margin growth in the year to March 2016.
The secure payment products and customer contact solutions provider is becoming increasingly confident that the current year could be a breakthrough period for the US business, with the US arm having already closed two multi-million dollar deals in June.
Finnish drug developer Faron Pharmaceutical Ltd (LON:FARN) is to broaden the scope of cancer treatment Clevegen after promising pre-clinical results
Clevegen is a novel cancer treatment that produces a antibody that converts the immune environment around a tumour from being immune suppressive to immune stimulating.
Like London buses, the contract wins for portfolio analysis software provider StatPro Group PLC (LON:SOG) are coming in bunches.
Hot on the heels of last week’s announcement of a deal with an Australian financial institution, the company has announced a five-year contract with a global American financial institution, worth a minimum of US$1.75mln (£1.2mln).
Clinigen Group PLC (LON:CLIN) has signed an exclusive global access agreement with private pharma Galen for chemotherapy drug DaunoXome.
Idis GA, Clinigen’s global access division, will make the drug available on request in 20 European countries as well as Australia, New Zealand and Hong Kong.